Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Biofrontera holds meeting with FDA regarding planned application for Ameluz

July 25, 2012

Berg Pharma kicks off phase I trial of BPM-31543

July 24, 2012

Leo Pharma designs new ingenol derivatives

July 24, 2012

Tissue Therapies obtains CE Mark for VitroGro ECM wound care product

July 16, 2012

Novel cell migration modulators designed in Japan

July 12, 2012

Pergamum reports topline data from phase II trial in prevention of postsurgical adhesions

July 10, 2012

Sirnaomics plans siRNA-based therapeutic study in China

July 6, 2012

Tissue Therapies provides update on CE mark application for wound-healing product

July 4, 2012

CHMP issues opinion on Zyclara MAA

June 28, 2012

Dosing begins in RXI-109 dermal scarring study

June 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...